Related Experiment Video
Updated: Apr 20, 2026
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
14.8K
Mirizzi Syndrome: How it could be a challenge
Hepato-Gastroenterology
|December 2, 2014
Summary
Mirizzi syndrome (MS), a rare cause of obstructive jaundice, requires careful diagnosis to prevent bile duct injury. This study details clinical presentations, management, and outcomes for 65 MS patients.
Area of Science:
- Gastroenterology
- Hepatobiliary Surgery
- Diagnostic Imaging
Background:
- Mirizzi syndrome (MS) is a rare complication of gallstones (cholelithiasis).
- It presents as obstructive jaundice and is crucial for differential diagnosis.
- Misdiagnosis can lead to severe bile duct injury.
Purpose of the Study:
- To describe the clinical features, diagnostic methods, surgical interventions, and endoscopic management of Mirizzi syndrome.
- To analyze the outcomes and complications associated with different treatment modalities.
Main Methods:
- Retrospective analysis of 65 patients diagnosed with Mirizzi syndrome.
- Diagnostic tools included magnetic resonance cholangiopancreatography (MRCP) and endoscopic retrograde cholangiopancreatography (ERCP).
- Patients were classified using the McSherry classification into Type I and Type II MS.
Main Results:
- The incidence of MS was 0.98% among 4600 cholecystectomy patients.
- Of 65 MS patients, 20 were treated solely with ERCP (18 stented, 2 stone extraction).
- 45 patients underwent surgery, with 18 having Type I MS and 27 having Type II MS.
Conclusions:
- Mirizzi syndrome necessitates a high index of suspicion in patients with obstructive jaundice.
- Management strategies, including ERCP and surgery, vary based on MS type and patient presentation.
- Accurate preoperative diagnosis and tailored treatment are key to minimizing complications.
More Related Videos
05:05Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
Published on: June 17, 2025
1.6K
11:53Laparoscopic Oocyte Retrieval and Cryopreservation during Vaginoplasty for Treatment of Mayer-Rokitansky-Kuster-Hauser Syndrome
Published on: May 10, 2022
4.6K
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
491
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
491
01:25Mitral Regurgitation III: Medical Management
632
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
632
01:20Myasthenia Gravis: Overview and Treatment
3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
01:24Cystic Fibrosis: Management
656
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
656
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
520
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
520
01:26Nephrotic Syndrome II : Assessment and Medical Management
387
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
387